Phase 2a Study of Baxdrostat in Primary Aldosteronism.

Saved in:
Bibliographic Details
Title: Phase 2a Study of Baxdrostat in Primary Aldosteronism.
Authors: Turcu AF; University of Michigan, Ann Arbor., Freeman MW; Harvard Medical School, Boston., Bancos I; Mayo Clinic, Rochester, MN., Ben-Shlomo A; Cedars-Sinai Medical Center, Los Angeles., Hamidi O; University of Texas Southwestern Medical Center, Dallas., Hamrahian AH; Johns Hopkins University, Baltimore., Huang W; Northwestern University Feinberg School of Medicine, Chicago., Kirschner LS; Ohio State University Wexner Medical Center, Columbus., Sam R; University of California, San Francisco, San Francisco., Mallappa A; AstraZeneca, Gaithersburg, MD., Tuyishimire B; AstraZeneca, Gaithersburg, MD., Lihn AS; AstraZeneca, Gothenburg, Sweden., Perl S; AstraZeneca, Gaithersburg, MD., Brown MJ; Queen Mary University of London, London.
Corporate Authors: SPARK Investigator Group
Source: The New England journal of medicine [N Engl J Med] 2025 Jul 31; Vol. 393 (5), pp. 515-518. Date of Electronic Publication: 2025 Jul 13.
Publication Type: Letter
Journal Info: Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1533-4406
DOI:10.1056/NEJMc2508629